Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Auteur de référence en rhumatologie
50 articles scientifiques publiés — un praticien à la pointe de la recherche
Référence presse grand public
Cité 6 fois dans les médias — pédagogie reconnue
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté
25 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
16
16 articles ont été cités au moins 16fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
18 911
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
34
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
17
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Epidemiology and management of malignancies in patients with inborn errors of immunity—An ESID registry study of 19,959 patients
2026ArticleJournal of Allergy and Clinical Immunology
Vinimag : système automatisé de microvinification (<1 kg) dédié aux vins rouges pour l'expérimentation viti-vinicole
2025ArticleInnovations Agronomiques
Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients
2025ArticleJournal of Human Immunity
Automated red microvinification (1kg) adapted to the needs of varietal innovation
2024Congrès45th World Congress of Vine and Wine
Analysis of volatile compounds production kinetics: A study of the impact of nitrogen addition and temperature during alcoholic fermentation
2023ArticleFrontiers in Microbiology
New Online Monitoring Approaches to Describe and Understand the Kinetics of Acetaldehyde Concentration during Wine Alcoholic Fermentation: Access to Production Balances
2023ArticleFermentation
Transports publics : la « marche vers la gratuité » s'accélère...
2022ArticleTransports, Infrastructures & Mobilité
A review of solar forecasting, its dependence on atmospheric sciences and implications for grid integration: Towards carbon neutrality
2022ArticleRenewable and Sustainable Energy Reviews
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CDS MEDICAL HAHNEMANN
1 RUE VERGNIAUD 99 BD AUGUSTE BLANQUI, 75013 PARIS
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 Top Santé · 21/12/2025
<a href="https://news.google.com/rss/articles/CBMiowJBVV95cUxPbjV0d21CR2ZrRHNPc05aUlRDT1BaandIMGQ3ZnlTdWFzanRuWkxxM3AtdElweDZRMFhiOWlocFBWR0FzRWVOTFhVZnpndmJSWktwNkJNSVo3NmRzSFdCWFdxTEtPd0xDMmJOX3oyNlNGZjU4eXhuQzUtd0hPcGJLaEI5YjVDcnlLeERHNlpfSUtXbXU2M3hhRzlvX1pVYTBOQ0d3Mmlzb01qMmx4S1BkRVYxMzhsQXVxaU
📰 Femme Actuelle · 18/10/2025
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxOU3lsQWF4ejJQUGgtSC1Xb3h5Tk5MOEJBWFl1dTQxS181U0ZDRFBycHI2VkFzRy12dTZJenFyVEFOR0R5V3FUdVpDbEF4eVJwTzBTZnZaNF80TC00OVJVRXZNMzF4ZlVKQ2lKanpnV2YtcHVsVmZadkNvaWhTRDY5MHVDNnRmYlFlckZoTWd3VU1CSWxuZjZOZVlwTkw5R21RTGZ6MURUWW9CQ29uN1ZDcHVpLXpJcmNRQ2
📰 Top Santé · 08/10/2024
<a href="https://news.google.com/rss/articles/CBMimAJBVV95cUxPX1NudWx4a215NGRYSUROQ2FEQmtMSG03dFl1U0tmOE5PZEMyMkpObFVYN3liUl9Fcm11a3N2MDJqa2lkZ19ONUpQSUl4REIwSjExTnBZOS1makFpM1NSenhvaUdtM2lUZFdkN2RDV05FMktUZjhBQkNPVjVjRlBwTzVYYlRnYmhMT1FyOEcwVS0tZkhEeVp2ZHB1bWRjRy1rODZvb3BCNkdnaFFuRmFKNmRveXVtNHU2QT
📰 ici.fr · 28/06/2019
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxQQ3RKdVVxSVVNWVVXcXc5ckFSSW9EN1I3ckdFMkxHWEFnbHlZbjVmVW9idVVwdnoyOUJUV1ROTVR1dWJKTlhCa1EyN3NRcWdzMlctOGZHMWZfamNnZWlEX25UazZIQkQ1WEtaM0FjYlZUSGN4NTVoeTRrQThkWkJ4aU1ETnJZMV9ZbktDemw3MGN5NXFtZzNuTEZWaFF1bVozbExwUERkN29MYVhqN2VIdVNJai1wSkZoSX
📰 ladepeche.fr · 30/01/2016
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxNaEs2NTg1aFFnM0hvdm53ZWUyLTFnYjByREwzb3RfXzNQTDJUYnhpUVRyZ05VTFd6RnYwLVRFWlFtUkpIM3BSTWt1SzhxYkMyelV4RVZvaGNrMWxSbTV4VE82VzJEQVg1VzJhRVNtZ1ZtYkZORElQZUhZYmpYa2dGRW8zcVU4aDRGdUM1NkEyMW1hdWk0QXJFUWg5VzJlVUN3cUdRdk1YazFUS1U?oc=5" target="_bla
📰 Ouest-France · 29/01/2010
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPRURwMkJwaUFQZklGQ3ZRd0xZN2JScUFuakZVc2E3Mmpycl9RMDhuWDltTTlsM1prQy1wU0ltTzl3N2tWMkE0ZVJRbG5jS2hCNXFEcDB6MjJPUWlfTnhFc1E5ajBIZzViZTltQWNWLWw3OUxET3F6OTM4MG5obWZJXzkxOGdWdUZUVXRvN2UzY3RtLVNVRnFwczA4aGdHRzhKZkNMVVpQOUpnUVl0aEZNN2lPa3pNVUtnSV
The New England journal of medicine · 2023
Obstetrics and gynecology · 2025
OBJECTIVE: To evaluate descriptive efficacy data, exploratory immunogenicity data, and safety follow-up through study completion from the global, phase 3 MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal vaccination trial of bivalent respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVpreF). METHODS: MATISSE was a phase 3, randomized, double-blinded, placebo-controlled trial. Healthy pregnant participants aged 49 years or younger at 24–36 weeks of gestation were randomized (1:1) to receive a single RSVpreF 120 micrograms or placebo dose. Primary efficacy endpoints included newborn and infant severe RSV-associated medically attended lower respiratory tract illness within 180 days after birth. The RSV-A and RSV-B serum neutralizing antibody titers were determined in a subset of pregnant participants and their newborns. RESULTS: In this final analysis, 7,420 pregnant participants were randomized, and 7,307 children were born (RSVpreF n=3,660, placebo n=3,647). Vaccine efficacy, defined as protection against newborn and infant severe RSV-associated medically attended lower respiratory tract illness, was 82.4% (95% CI, 57.5–93.9) and 70.0% (95% CI, 50.6–82.5) within 90 and 180 days of birth, respectively. The RSVpreF induced robust immune responses in pregnant participants and resulted in highly efficient transfer of maternal antibodies to their newborns across subgroups (by gestational age at delivery and at vaccination, number of days from vaccination to delivery, country, maternal age). Final RSVpreF safety results in pregnant and newborn and infant participants were consistent with the primary analysis with no new safety concerns identified. CONCLUSION: This final analysis of MATISSE trial data confirms the primary analysis conclusions: Maternal vaccination with RSVpreF has a favorable safety profile in both pregnant and newborn and infant participants and demonstrates efficacy against RSV-associated lower respiratory tract illness in infants through age 6 months. The RSVpreF induces robust immune responses in pregnant individuals, with corresponding high RSV-neutralizing titers in their newborns. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT04424316.
Frontiers in pediatrics · 2021
Background: Following the spread of the coronavirus disease 2019 (COVID-19) pandemic a new disease entity emerged, defined as Pediatric Inflammatory Multisystem Syndrome temporally associated with COVID-19 (PIMS-TS), or Multisystem Inflammatory Syndrome in Children (MIS-C). In the absence of trials, evidence for treatment remains scarce.Purpose: To develop best practice recommendations for the diagnosis and treatment of children with PIMS-TS in Switzerland. It is acknowledged that the field is changing rapidly, and regular revisions in the coming months are pre-planned as evidence is increasing.Methods: Consensus guidelines for best practice were established by a multidisciplinary group of Swiss pediatric clinicians with expertise in intensive care, immunology/rheumatology, infectious diseases, hematology, and cardiology. Subsequent to literature review, four working groups established draft recommendations which were subsequently adapted in a modified Delphi process. Recommendations had to reach &gt;80% agreement for acceptance.Results: The group achieved agreement on 26 recommendations, which specify diagnostic approaches and interventions across anti-inflammatory, anti-infectious, and support therapies, and follow-up for children with suspected PIMS-TS. A management algorithm was derived to guide treatment depending on the phenotype of presentation, categorized into PIMS-TS with (a) shock, (b) Kawasaki-disease like, and (c) undifferentiated inflammatory presentation.Conclusion: Available literature on PIMS-TS is limited to retrospective or prospective observational studies. Informed by these cohort studies and indirect evidence from other inflammatory conditions in children and adults, as well as guidelines from international health authorities, the Swiss PIMS-TS recommendations represent best practice guidelines based on currently available knowledge to standardize treatment of children with suspected PIMS-TS. Given the absence of high-grade evidence, regular updates of the recommendations will be warranted, and participation of patients in trials should be encouraged.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
JBMR plus · 2026 · Journal Article
Perez MO, Sales LP, Jorgetti V, Caparbo VF, et al.
The Journal of arthroplasty · 2026 · Journal Article
Pekas DR, Perez M, Mansager SA, Discordia AK, et al.
Cureus · 2025 · Case Reports
Reid BE, Perez M, Abd Elmageed Z, DiGiuseppe S, et al.
Scientific reports · 2025 · Journal Article
Pérez MM, Rissech C, Porta-Vilaró M, Reguera C, et al.
Cureus · 2025 · Case Reports
Tole MC, Perez MV, Mekonen YF, Bermudez M, et al.
RMD open · 2025 · Journal Article
Ahijón Lana M, Sivera Mascaró F, Fernández-Nebro A, Muntadas Castelló S, et al.
The Journal of bone and joint surgery. American volume · 2025 · Journal Article
Pekas DR, Perez M, Yu-Shan AA, Bailey C, et al.
International journal of rheumatic diseases · 2024 · Journal Article
de Santana FM, de Carvalho JF, Spolidoro N, Fuoco L, et al.
The Journal of infectious diseases · 2024 · Journal Article
Goswami J, Baqui AH, Doreski PA, Perez Marc G, et al.
Disease models & mechanisms · 2024 · Journal Article
Akinyele O, Munir A, Johnson MA, Perez MS, et al.
Reumatologia clinica · 2024 · Journal Article
Otón T, Messina OD, Fernández Ávila DG, Robles San Román M, et al.
European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2023 · Journal Article
Corona PS, Pérez M, Vicente M, Pujol O, et al.
Annals of the rheumatic diseases · 2023 · Journal Article
Collins JA, Kim CJ, Coleman A, Little A, et al.
Frontiers in immunology · 2023 · Journal Article
Sales LP, Hounkpe BW, Perez MO, Caparbo VF, et al.
Revista da Associacao Medica Brasileira (1992) · 2023 · Editorial
Perez MO, Pedro PPA, Lyrio AM, Grizzo FMF, et al.
Archives of dermatological research · 2023 · Journal Article
Vazquez T, Forouzandeh M, Lin D, Chin F, et al.
Frontiers in microbiology · 2023 · Journal Article
Godillot J, Baconin C, Sanchez I, Baragatti M, et al.
Journal of the American College of Surgeons · 2022 · Journal Article
Perez M, Hansen CP, Burdio F, Pellino G, et al.
International journal of rheumatic diseases · 2022 · Journal Article
Figueiredo CP, Perez MO, Sales LP, Domiciano DS, et al.
Biosensors · 2022 · Journal Article
Bourguignon N, Karp P, Attallah C, Chamorro DA, et al.
Veterinary pathology · 2022 · Journal Article
Vidal E, López-Figueroa C, Rodon J, Pérez M, et al.
Frontiers in rehabilitation sciences · 2022 · Journal Article
Leochico CFD, Perez MFJ, Mojica JAP, Ignacio SD
Arthritis & rheumatology (Hoboken, N.J.) · 2022 · Journal Article
Perez MO, Figueiredo CP, Sales LP, Medeiros-Ribeiro AC, et al.
Frontiers in microbiology · 2022 · Journal Article
Godillot J, Sanchez I, Perez M, Picou C, et al.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2021 · Journal Article
Perez MT, Owen JR, Wayne JS
Therapeutic advances in musculoskeletal disease · 2021 · Journal Article
Coste J, Medkour T, Maigne JY, Pérez M, et al.
Journal of medical ultrasound · 2021 · Case Reports
Sahoo RK, Galluccio F, Chang KV, Perez MF
International journal of rheumatic diseases · 2021 · Journal Article
Figueiredo CP, Perez MO, Sales LP, Caparbo VF, et al.
Clinical rheumatology · 2021 · Journal Article
Furlam PL, Perez MO, Franco AS, Caparbo VF, et al.
Reumatologia clinica · 2021 · Practice Guideline
Cardiel MH, Carrillo S, Pérez M, Andrade L, et al.
International journal of rheumatic diseases · 2021 · Journal Article
Molina Collada J, Castrejón I, Pérez M, Nieto-González JC, et al.
Modern rheumatology · 2021 · Journal Article
Figueiredo CP, Perez MO, Sales LP, Schett G, et al.
Journal of shoulder and elbow surgery · 2021 · Journal Article
Pitocchi J, Plessers K, Wirix-Speetjens R, Debeer P, et al.
Obstetrics and gynecology · 2025 · Journal Article
Simões EAF, Pahud BA, Madhi SA, Kampmann B, et al.
Vaccine · 2025 · Clinical Trial, Phase II
Perez Marc G, Coria LM, Ceballos A, Rodriguez JM, et al.
Frontiers in immunology · 2024 · Journal Article
Hounkpe BW, Sales LP, Ribeiro SCR, Perez MO, et al.
Seminars in arthritis and rheumatism · 2023 · Journal Article
Ribeiro SCCR, Sales LP, Fernandes AL, Perez MO, et al.
Vaccine · 2025 · Clinical Trial, Phase II
Perez Marc G, Coria LM, Ceballos A, Rodriguez JM, et al.
Therapeutic advances in musculoskeletal disease · 2021 · Journal Article
Coste J, Medkour T, Maigne JY, Pérez M, et al.
Annals of surgery · 2024 · Journal Article
Villasante S, Fernandes N, Perez M, Cordobés MA, et al.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2024 · Journal Article
Perez M, Palnaes Hansen C, Burdio F, Sanchez-Velázquez P, et al.
Journal of pediatric hematology/oncology · 2023 · Review
Watts S, Diaz M, Teller C, Hamby T, et al.
Frontiers in pediatrics · 2021 · Journal Article
Schlapbach LJ, Andre MC, Grazioli S, Schöbi N, et al.
Therapeutic advances in musculoskeletal disease · 2023 · Case Reports
Lam KHS, Wu YT, Reeves KD, Hadzic A, et al.
Archives of osteoporosis · 2021 · Journal Article
Pereira RMR, Perez MO, Paula AP, Moreira C, et al.
Gates open research · 2021 · Journal Article
Esteban I, Bergero G, Alves C, Bronstein M, et al.
Journal of clinical medicine · 2023 · Journal Article
Otobo TM, Tolend M, Meyers AB, Sudol-Szopinska I, et al.
Reumatologia clinica · 2023 · Case Reports
Pérez ML, Laso RV, Velasco-Rodríguez D, Martín-Herrero S, et al.
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons · 2021 · Journal Article
Miranda MAM, Martins C, Cortegana IM, Campos G, et al.
The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons · 2021 · Journal Article
Miranda MAM, Martins C, Cortegana IM, Campos G, et al.
CCDC 1439457: Experimental Crystal Structure Determination
Related Article: Marc Perez, Tahar Ayad, Philippe Maillos, Valérie Poughon, Jacques Fahy, Virginie Ratovelomanana-Vidal|2016|Synlett|27|1077|doi:10.1055/s-0035-1561340
CCDC 1499318: Experimental Crystal Structure Determination
Related Article: Marc Perez, Saravanakumar Elangovan, Anke Spannenberg, Kathrin Junge, Matthias Beller|2016|ChemSusChem|9|1|doi:10.1002/cssc.201501673
La mobilité en milieu urbain : de la préférence pour la congestio a la préférence pour l'environnement ?
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
To gain further insight into the genetic architecture of psoriasis, we conducted a meta-analysis of 3 genome-wide association studies (GWAS) and 2 independent data sets genotyped on the Immunochip, including 10,588 cases
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Obstetrics and gynecology · 2025 · Journal Article
Madhi SA, Kampmann B, Simões EAF, Zachariah P, et al.
The New England journal of medicine · 2023 · Clinical Trial, Phase II
Wilson E, Goswami J, Baqui AH, Doreski PA, et al.
✨ Profil synthétique
IA · 19/05/2026Le Dr Marc PEREZ est un rhumatologue salarié à Paris, avec une activité de recherche centrée sur les infections virales respiratoires et le COVID-19. Il a publié 34 articles et possède un h-index de 16 selon OpenAlex. Ses publications sur PubMed couvrent des sujets tels que la pharmacovigilance, l'arthrite juvénile et l'utilisation de l'intelligence artificielle en rhumatologie.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.